Founders, we keep talking about AI as if it were one market. It is not. And we keep seeing the insatiable appetite of the big AI Labs as if there was not limit : consumer, corporate, governments. No, they won’t take over all markets. I believe...
Two weeks ago, I wrote about the "SaaSpocalypse"—the $1.8 trillion market-cap wipeout triggered by the realization that AI agents are no longer just "helpers," but potential replacements for the software itself. The crash isn't a "SaaSpocalypse", it's the start of a great filter. As AI...
If you’re building (or are invested in) SaaS today, read this before you panic. The market is right about the AI threat to traditional SaaS. But it's wrong to say SaaS is dead. Last week, a single AI product announcement (Anthropic Co-Work) erased $1.8 trilion in software...
How to Break the “Law” of 100% Growth Most startups settle around 2x, sometimes 3x annual revenue growth (100-200% YoY). Not because the market limits them — but because their internal systems are architected and calibrated for it. To grow 5-10x in a year, you cannot just try...
Expon Capital continues to back visionary founders, driving innovation across Europe and beyond....
Over the past 15 years, Europe’s startup ecosystem has matured with proven playbooks, experienced mentors, and data-driven VC strategies driving stronger outcomes....
How has VC evolved and what does it mean for investors? Europe's VC Scene Isn't About Luck Anymore—It's About Playbooks Over the past 10-15 years, Europe's startup ecosystem has experienced a significant transformation. Fifteen years ago, founders and VCs often depended on theoretical strategies and a bit...
Expon Capital is excited to have co-led a €6m Series A together with HealthCap, to support HelloBetter, a leading science-based Prescription Digital Therapeutics provider for a broad range of mental health conditions. Sparrow Ventures and the existing investor, Hevella Capital, also participated in the round....
Expon Capital is excited to have co-led a €6m Series A together with HealthCap, to support HelloBetter, a leading science-based Prescription Digital Therapeutics provider for a broad range of mental health conditions. Sparrow Ventures and the existing investor, Hevella Capital, also participated in the round....
Expon Capital is excited to have co-led a €6m Series A together with HealthCap, to support HelloBetter, a leading science-based Prescription Digital Therapeutics provider for a broad range of mental health conditions. Sparrow Ventures and the existing investor, Hevella Capital, also participated in the round....